hotspot -WSS

hotspot

author：leisure time 2025-09-06 02:11:30 - browse：89

Balance innovation — A federal judge made a key ruling in a lawsuit challenging a new drug pricing program Adobe

WASHINGTON — A federal court judge allowed a new Medicare drug price negotiation program to proceed while the court deliberates whether it is constitutional.

The case centers on Democrats’ new law, which empowered the Medicare program to start negotiating lower prices for certain medicines that are especially expensive for the government. Judge Michael Newman, a Trump appointee to the U.S. District Court for the Southern District of Ohio, ruled against the U.S. Chamber of Commerce, which had sued the federal government and asked for the program to be stopped while litigation continues.

Medicare officials announced the first 10 drugs they would negotiate over last month, and the deadline for the pharmaceutical companies to sign agreements to start bargaining is Oct. 1. The Chamber of Commerce had requested a decision on the preliminary injunction by that date.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Wikipedia

WSS

Eliminate the waiting period for sterilization covered by Medicaid

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Hospital price transparency does save money, advocate argues

The Readout: Lenmeldy, GLP

Senate committee scrutinizes Medicare Advantage brokers

Covid vaccine financial winners and losers, from Pfizer to Novavax

focus

hotspot

knowledge

Medical leaders decry Supreme Court decision on affirmative action

Eli Lilly expects to double planned employment in Boston center

Apple is now the first public company to be valued at $3 trillion

FDA warns J&J's Abiomed: We will regulate your software

Guidelines to prevent youth baseball injuries need more muscle

STAT Summit: Biotech founders on deal

Alkermes shareholders re

There's no autism epidemic. It's an autism diagnosis epidemic

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

focus

Roche subsidiary Foundation Medicine opens new headquarters

Steward Health Care has deal to sell doctor network to UnitedHealth

Donor acceptance rates hint at racial, gender bias in heart transplants: study

STAT Readout Newsletter: Today's biggest biotech updates

Washington mulls new rules to avert another Change Healthcare

Merck drug for rare lung condition set for approval in U.S.

Wikipedia

entertainment

hotspot

focus